Partners Group Holding’s AngioDynamics ANGO Stock Holding History

Partners Group Holding’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-331,829	Closed	-$5.76M	–	43
2017 Q1	$5.76M	Hold	331,829	–	–	0.46%	26
2016 Q4	$5.6M	Buy	+331,829	New	+$5.53M	0.84%	23
2015 Q1	–	Sell	-615,866	Closed	-$11.7M	–	37
2014 Q4	$11.7M	Hold	615,866	–	–	2.68%	15
2014 Q3	$8.45M	Buy	+615,866	New	+$8.79M	1.85%	22

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Partners Group Holding's ANGO Position: Q2 2017 in Review

Partners Group Holding sold out of AngioDynamics (ANGO) in Q2 2017, closing a stake of 331,829 shares — an estimated $5.76M sold.

Partners Group Holding first reported a position in ANGO in Q3 2014 and held it in 4 quarters. The position peaked at $11.7M in Q4 2014. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2017.

Partners Group Holding reported no remaining AngioDynamics position as of Q2 2017 after selling out during the quarter.
Partners Group Holding sold 331,829 AngioDynamics shares in Q2 2017, an estimated $5.76M.
Partners Group Holding first reported a position in AngioDynamics in Q3 2014 and held it in 4 quarters.
Partners Group Holding's AngioDynamics position peaked at $11.7M in Q4 2014.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2017.

Based on Partners Group Holding's 13F filing for Q2 2017, filed 14 Aug 2017.